These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5514621)

  • 21. Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma.
    Jones MM; Basinger MA
    Anticancer Res; 1989; 9(6):1937-41. PubMed ID: 2627140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
    DeWys WD; Humphreys SR; Goldin A
    Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
    [No Abstract]   [Full Text] [Related]  

  • 23. THE TRANSPLANTABILITY OF TUMOURS BY INTRAVENOUS AND INTRALYMPHATIC ROUTES.
    WALLACE AC; HOLLENBERG NK
    Br J Cancer; 1965 Jun; 19(2):338-42. PubMed ID: 14316210
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the antitumor activity of rifamycin SV.
    Adamson RH
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):61-5. PubMed ID: 5093193
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of Iscador (Viscum praeparatum M.) on the Walker carcinosarcoma of the rat (author's transl)].
    Seitz W
    Wien Klin Wochenschr; 1975 Feb; 87(4):131-2. PubMed ID: 1130081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of thymosterine B on the development of Walker carcinosarcoma 256 treated with BCG in rats].
    Potop I; Zimel A
    Endocrinologie; 1980; 18(1):19-21. PubMed ID: 6987725
    [No Abstract]   [Full Text] [Related]  

  • 28. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
    Maliugina LL; Pol'kina RI
    Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803
    [No Abstract]   [Full Text] [Related]  

  • 29. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
    Pütter J; Maral R; Bierling R; Steinhoff D
    Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
    Volm M; Mattern J; Weber N; Wayss K
    Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lactate dehydrogenase isoenzymatic spectrum in rats with Walker carcinosarcoma].
    Zel'vin BM; Bolonina NI; Tereshchenko IP
    Vopr Onkol; 1974; 20(4):76-9. PubMed ID: 4439819
    [No Abstract]   [Full Text] [Related]  

  • 32. Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
    Radzikowski C
    Mater Med Pol; 1976; 8(3):345-9. PubMed ID: 1034860
    [No Abstract]   [Full Text] [Related]  

  • 33. A simple method to establish simulated gastric and intestinal cancer in rats by mucosal implantation of Walker tumour.
    Broyn T
    Acta Chir Scand; 1974; 140(6):481-5. PubMed ID: 4428926
    [No Abstract]   [Full Text] [Related]  

  • 34. A lapachol derivative active against mouse lymphocytic leukemia P-388.
    da Consolação M; Linardi F; de Oliveira MM; Sampaio MR
    J Med Chem; 1975 Nov; 18(11):1159-61. PubMed ID: 1177264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetics of the change in free radical content during the development of Walker carcinosarcoma and the action of Thio-TEPA].
    Saprin AN; Minenkova EA; Nagler LG; Kaznacheev IuS; Krugliak SA; Krugliakova KE; Emanuél' NM
    Biofizika; 1967; 12(6):1099-103. PubMed ID: 4318224
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
    Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
    Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behaviour of clostridial antibodies in rats with transplantable tumours under therapy by cyclophosphamide (author's transl)].
    Kretschmer H; Hambsch K; Ludewig R
    Arch Geschwulstforsch; 1974; 44(2):103-5. PubMed ID: 4471604
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats.
    Harrison EF; Fuquay ME; Hunter HL
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):25-8. PubMed ID: 6836324
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth inhibition of rat mammary carcinoma induced by cis-platinum diamminodichloride-II.
    Welsch CW
    J Natl Cancer Inst; 1971 Nov; 47(5):1071-8. PubMed ID: 5123334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.